"Not sure how this extended deadline will work with the ALK placement"
Nevermind got too excited and didn't finish reading the announcement:
If the Alkane Transaction completes, Ramelius will not proceed with the offer and Explaurum shareholders will not be entitled to receive the consideration from Ramelius.
Also, my point about EXU management not doing much seems pretty accurate given:
"Ramelius has taken this step, in light of approaches received from Explaurum shareholders and has received written indications of support for this proposal from shareholders representing approximately 14.3% of Explaurum which when combined with acceptances already received under the Offer, totals 19.9% of Explaurum."
When the shareholders achieve more for each other than management you've got to start asking questions...
EXU Price at posting:
8.5¢ Sentiment: Hold Disclosure: Held
